Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Raze Therapeutics launches with $24mm Series A

Executive Summary

Oncology start-up Raze Therapeutics emerged from stealth mode and raised $24mm through its Series A round. Atlas Venture, MPM Capital Management, and Partners Innovation Fund were joined by venture funds associated with a few major pharmacos as well--Astellas Venture Management (Astellas Pharma Inc.), MS Ventures (Merck Serono SA), and Novartis AG.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register